Market Overview

The Global Hepatitis Diagnostic Test Market was valued at USD 4,424.03 million in 2023 and is expected to reach USD 6,945.49 million by 2031 while growing at a CAGR of 5.8% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global hepatitis diagnostic test market growth. Hepatitis diagnostic tests are employed to detect and diagnose inflammation of the liver, known as hepatitis. This condition is primarily caused by viral infections, but other factors such as alcohol abuse, autoimmune diseases, and certain medications can also contribute. The tests aim to pinpoint the underlying cause of hepatitis, evaluate the extent of liver damage, and direct suitable treatment and management plans.

The rising prevalence of hepatitis, coupled with technological advancements like rapid diagnostic tests and nucleic acid testing (NAT), propels the hepatitis diagnostic test market forward. Nonetheless, high costs and societal stigma could hinder market growth.

Furthermore, the global hepatitis diagnostic test industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Test Type Analysis

The Global Hepatitis Diagnostic Test Market is segmented among Blood Tests, Imaging Test, and Liver Biopsy, based on Test Type. In 2023, Blood Tests accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Hepatitis Diagnostic Test Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc), BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, VWR International, LLC, Qaigen Inc, and Grifols SA.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Hepatitis Diagnostic Test Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Hepatitis Diagnostic Test Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Hepatitis Diagnostic Test Market Segmentation, By Test Type

• Global Hepatitis Diagnostic Test Market Share Analysis, By Test Type

• Global Hepatitis Diagnostic Test Market Growth Analysis, By Test Type

• Global Hepatitis Diagnostic Test Market Trends, By Test Type

o Blood Tests

Ø Liver Function Tests

Ø Immunoassays

Ø Nucleic Acid Tests

o Imaging Test

o Liver Biopsy

6. Global Hepatitis Diagnostic Test Market Segmentation, By Region

• Global Hepatitis Diagnostic Test Market Share Analysis, By Region

• Global Hepatitis Diagnostic Test Market Growth Analysis, By Region

• Global Hepatitis Diagnostic Test Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Danaher Corporation (Beckman Coulter Inc)

• BioMerieux SA

• Bio-Rad Laboratories Inc

• Diasorin S.p.A

• F. Hoffmann-La Roche AG

• Hologic Inc

• VWR International, LLC

• Qaigen Inc

• Grifols SA

*Similar analysis will be provided for each company listed above.